share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

SEC ·  Jul 26 06:19
Summary by Futu AI
Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on July 23, 2024. The transaction was executed on the open market at a price of $8.4774 per share, resulting in a total sale value of approximately $97,040.80. Following the sale, Borgeson's direct holdings in the company amount to 7,155,663 shares. The sale reflects a transaction in the company's common stock and is part of the normal course of trading activities.
Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on July 23, 2024. The transaction was executed on the open market at a price of $8.4774 per share, resulting in a total sale value of approximately $97,040.80. Following the sale, Borgeson's direct holdings in the company amount to 7,155,663 shares. The sale reflects a transaction in the company's common stock and is part of the normal course of trading activities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated